Enoki mushrooms recalled after CFIA testing finds Listeria
Longsheng (Canada) Agricultural Products Ltd. is recalling Ming Xiang brand Enoki Mushrooms because of possible Listeria monocytogenes contamination.
This recall was triggered by Canadian Food Inspection Agency test results.
The recalled product has been sold in British Columbia and may have been distributed in other provinces and territories.
|Ming Xiang||Mushroom (enoki)||200 g||8 847108 270063||All units sold up to and including April 4, 2022|
As of the posting of this recall, there have been no reported illnesses associated with the consumption of this product.
Consumers should check to see if they have the recalled product in their homes. Recalled products should be thrown out or returned to the location where they were purchased.
About Listeria infections
Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still cause serious and sometimes life-threatening infections. Anyone who has eaten any recalled product and developed symptoms of Listeria infection should seek medical treatment and tell their doctors about the possible Listeria exposure.
Also, anyone who has eaten any of the recalled products should monitor themselves for symptoms during the coming weeks because it can take up to 70 days after exposure to Listeria for symptoms of listeriosis to develop.
Symptoms of Listeria infection can include vomiting, nausea, persistent fever, muscle aches, severe headache, and neck stiffness. Specific laboratory tests are required to diagnose Listeria infections, which can mimic other illnesses.
Pregnant women, the elderly, young children, and people such as cancer patients who have weakened immune systems are particularly at risk of serious illnesses, life-threatening infections, and other complications. Although infected pregnant women may experience only mild, flu-like symptoms, their infections can lead to premature delivery, infection of the newborn, or even stillbirth.
(To sign up for a free subscription to Food Safety News, click here.)